BRIEF-Lee's Pharmaceutical Holdings Limited Acquires Staccato One Breath Technology Platform And Assets, Driving Pipeline Expansion And Advancing Global Partnership With UCB Through Acquired Rights

Dec 9 (Reuters) - Lee's Pharmaceutical Holdings Ltd 0950.HK:

  • LEE'S PHARMACEUTICAL HOLDINGS LIMITED ACQUIRES STACCATO® ONE BREATH TECHNOLOGY® PLATFORM AND ASSETS, DRIVING PIPELINE EXPANSION AND ADVANCING GLOBAL PARTNERSHIP WITH UCB THROUGH ACQUIRED RIGHTS

  • LEE'S PHARMACEUTICAL HOLDINGS LTD: CO TOGETHER WITH NPI MAY RECEIVE MILESTONE PAYMENTS TOTALLING UP TO US$60.5 MILLION

Source text: ID:nPn8wCPLqa

Further company coverage: 0950.HK


((Reuters.Briefs@thomsonreuters.com;))

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.